ALLIGEN / Research & News
Antimicrobial Resistance / Genomic Epidemiology

Food-Chain Salmonella Genomes Reveal High-Risk Resistance Traits and Uncertain Future Trends

2026-10-22 · Source date: 2026-10-20

Genomic surveillance across China's food chain has identified antimicrobial-resistance patterns that deserve attention beyond conventional counts of resistant clinical isolates. A Nature Communications study published October 20 analysed 2,536 multidrug-resistant Salmonella genomes and examined the distribution of high-risk genetic traits across food-associated settings.

Salmonella can move through interconnected reservoirs that include livestock, food products, workers and consumers. Whole-genome sequencing helps investigators examine resistance genes and their genomic context, distinguish related bacterial lineages and assess whether mobile genetic elements may contribute to the movement of resistance determinants. However, finding the same gene in multiple settings does not by itself demonstrate a specific transmission event.

The study reports associations between resistance-related genomic features and factors including antibiotic use and population growth. Its modelling explores possible trajectories through 2050, with particular concern around determinants linked to last-resort agents such as carbapenems and colistin. Those future estimates depend on the model's assumptions and should not be presented as forecasts that are certain to occur.

An important finding is the attention given to people working along the food chain, a population that can be overlooked when surveillance is divided into human clinical and animal-production datasets. Integrating worker, animal, environmental and food sampling may reveal connections that siloed programmes miss. The study also illustrates why gene detection should be complemented by susceptibility testing and careful interpretation of gene expression, host species and genomic context.

The practical implication is a One Health surveillance design that combines harmonized sampling, standardized bioinformatics and transparent uncertainty reporting. The study is specific to the samples and settings analysed in China; it does not establish the prevalence of identical resistance patterns in other countries. Its broader relevance is methodological: genomic data can help identify where targeted interventions and better surveillance might have the greatest value.

Sources